139 related articles for article (PubMed ID: 34772874)
1. Facilitators and Barriers to Glaucoma Medication Adherence.
Gatwood J; Brooks C; Meacham R; Abou-Rahma J; Cernasev A; Brown E; Kuchtey RW
J Glaucoma; 2022 Jan; 31(1):31-36. PubMed ID: 34772874
[TBL] [Abstract][Full Text] [Related]
2. Communication Predicts Medication Self-Efficacy in Glaucoma Patients.
Carpenter DM; Blalock SJ; Sayner R; Muir KW; Robin AL; Hartnett ME; Giangiacomo AL; Tudor GE; Sleath BL
Optom Vis Sci; 2016 Jul; 93(7):731-7. PubMed ID: 27003815
[TBL] [Abstract][Full Text] [Related]
3. The Most Common Barriers to Glaucoma Medication Adherence: A Cross-Sectional Survey.
Newman-Casey PA; Robin AL; Blachley T; Farris K; Heisler M; Resnicow K; Lee PP
Ophthalmology; 2015 Jul; 122(7):1308-16. PubMed ID: 25912144
[TBL] [Abstract][Full Text] [Related]
4. Comparisons of Self-reported Glaucoma Medication Adherence With a New Wireless Device: A Pilot Study.
Gatwood JD; Johnson J; Jerkins B
J Glaucoma; 2017 Nov; 26(11):1056-1061. PubMed ID: 29099436
[TBL] [Abstract][Full Text] [Related]
5. Feasibility, Patient Acceptability, and Preliminary Efficacy of a Culturally Informed, Health Promotion Program to Improve Glaucoma Medication Adherence Among African Americans: "Glaucoma Management Optimism for African Americans Living with Glaucoma" (GOAL).
Dreer LE; Owsley C; Campbell L; Gao L; Wood A; Girkin CA
Curr Eye Res; 2016; 41(1):50-8. PubMed ID: 25625187
[TBL] [Abstract][Full Text] [Related]
6. Glaucoma medication adherence among African Americans: program development.
Dreer LE; Girkin CA; Campbell L; Wood A; Gao L; Owsley C
Optom Vis Sci; 2013 Aug; 90(8):883-97. PubMed ID: 23873033
[TBL] [Abstract][Full Text] [Related]
7. Patient Experience during the Support, Educate, Empower Glaucoma Coaching Program to Improve Medication Adherence: A Pilot Study.
Hollenhorst CN; Elliott V; Heisler M; Schneider K; Resnicow K; Newman-Casey PA
Ophthalmol Glaucoma; 2020; 3(4):238-252. PubMed ID: 33008556
[TBL] [Abstract][Full Text] [Related]
8. Factors Affecting Adherence to Topical Glaucoma Therapy: A Quantitative and Qualitative Pilot Study Analysis in Sydney, Australia.
Spencer SKR; Shulruf B; McPherson ZE; Zhang H; Lee MB; Francis IC; Bank A; Coroneo MT; Agar A
Ophthalmol Glaucoma; 2019; 2(2):86-93. PubMed ID: 32672609
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Patient Education and Telemedicine Reminders on Adherence to Eye Drops for Glaucoma.
Lai Y; Wu Y; Chai C; Yen CC; Ho Y; Eng TC; Jain P; Koh V
Ophthalmol Glaucoma; 2020; 3(5):369-376. PubMed ID: 32980041
[TBL] [Abstract][Full Text] [Related]
10. The Efficacy of the After-visit Summary in Medication Recall Among Glaucoma Patients.
Hirabayashi KJ; Pomerantz M; Radell JE; Chadha N; Thomas S; Serle JB
J Glaucoma; 2020 Jul; 29(7):529-535. PubMed ID: 32332333
[TBL] [Abstract][Full Text] [Related]
11. Text Parsing-Based Identification of Patients with Poor Glaucoma Medication Adherence in the Electronic Health Record.
Hamid MS; Valicevic A; Brenneman B; Niziol LM; Stein JD; Newman-Casey PA
Am J Ophthalmol; 2021 Feb; 222():54-59. PubMed ID: 32926847
[TBL] [Abstract][Full Text] [Related]
12. Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: the automated dosing reminder study.
Boland MV; Chang DS; Frazier T; Plyler R; Friedman DS
JAMA Ophthalmol; 2014 Jul; 132(7):838-44. PubMed ID: 24830878
[TBL] [Abstract][Full Text] [Related]
13. Barriers and adherence to glaucoma medication in a paediatric glaucoma population: A cross-sectional survey in central Saudi Arabia.
Al-Dawood A; Ahmad K; Al-Salman S; Al Hussan F; Al Houssien A; Al-Shahwan S; Khandekar R; Edward DP
Eur J Ophthalmol; 2022 Nov; 32(6):3451-3460. PubMed ID: 35469467
[TBL] [Abstract][Full Text] [Related]
14. The Impact of the Support, Educate, Empower Personalized Glaucoma Coaching Pilot Study on Glaucoma Medication Adherence.
Newman-Casey PA; Niziol LM; Lee PP; Musch DC; Resnicow K; Heisler M
Ophthalmol Glaucoma; 2020; 3(4):228-237. PubMed ID: 33012330
[TBL] [Abstract][Full Text] [Related]
15. User-centered Design of the eyeGuide: A Tailored Glaucoma Behavior Change Program.
Killeen OJ; MacKenzie C; Heisler M; Resnicow K; Lee PP; Newman-Casey PA
J Glaucoma; 2016 Oct; 25(10):815-821. PubMed ID: 27096721
[TBL] [Abstract][Full Text] [Related]
16. Noncompliance with glaucoma medication in Korean patients: a multicenter qualitative study.
Park MH; Kang KD; Moon J;
Jpn J Ophthalmol; 2013 Jan; 57(1):47-56. PubMed ID: 23065047
[TBL] [Abstract][Full Text] [Related]
17. Validation of a short version of the glaucoma medication self-efficacy questionnaire.
Sleath B; Blalock SJ; Stone JL; Skinner AC; Covert D; Muir K; Robin AL
Br J Ophthalmol; 2012 Feb; 96(2):258-62. PubMed ID: 21610264
[TBL] [Abstract][Full Text] [Related]
18. The relationship between quality of life and adherence to medication in glaucoma patients in Singapore.
Loon SC; Jin J; Jin Goh M
J Glaucoma; 2015; 24(5):e36-42. PubMed ID: 24248002
[TBL] [Abstract][Full Text] [Related]
19. Ophthalmologist-patient communication, self-efficacy, and glaucoma medication adherence.
Sleath B; Blalock SJ; Carpenter DM; Sayner R; Muir KW; Slota C; Lawrence SD; Giangiacomo AL; Hartnett ME; Tudor G; Goldsmith JA; Robin AL
Ophthalmology; 2015 Apr; 122(4):748-54. PubMed ID: 25542521
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of Patient-reported Adherence to Glaucoma Medications on a Visual Analog Scale Compared With Electronic Monitors.
Sayner R; Carpenter DM; Blalock SJ; Robin AL; Muir KW; Hartnett ME; Giangiacomo AL; Tudor G; Sleath B
Clin Ther; 2015 Sep; 37(9):1975-85. PubMed ID: 26164785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
